Official source Data mirrored from Centers for Medicare & Medicaid Services Open Payments · General Payments · CMS publication 2026-06-30 View official record

Covered recipient · General Payments record

LUIS A ROJAS-ESPAILLAT

Allopathic & Osteopathic Physicians Obstetrics & Gynecology Gynecologic Oncology

NPI
1548396054
CMS profile
1232751
Location
SIOUX FALLS, SD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

Saved items

Saved only in this browser. No account or alerts.

Filter and download payment records

General Payments · PY2023 · Entire year

$2,616.35

2 records · 0 disputed

Summary and payment records

  • CMS publication 2026-06-30
Read the payment records

“Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.”

— Centers for Medicare & Medicaid Services, Open Payments

A reported payment reflects a financial relationship a company disclosed. It does not indicate wrongdoing or a conflict of interest, and it says nothing about the quality of a provider's care.

These records are submitted to CMS and attested to by the reporting companies. CMS publishes them as reported; this site mirrors them without independent verification.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

How these totals are calculated
  • This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Methodology & Data — sourcing, labeling, and limitations.

Provider summaries generated . CMS updates this data on an annual cycle, and corrections or successful disputes made at CMS may not yet appear here. The official CMS record is authoritative for the current state. View the official CMS record ↗

By nature of payment

PY2023 · entire year · sorted by reported total

Nature of paymentAmountRecords
Consulting Fee $2,600.00 1
Food and Beverage $16.35 1

By paying entity

PY2023 · entire year · sorted by reported total

Paying entityAmountRecords
GlaxoSmithKline, LLC. $2,600.00 1
INTUITIVE SURGICAL, INC. $16.35 1

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Use the CSV download for all matching records.

IndustryPayments · General Payments

LUIS A ROJAS-ESPAILLAT

NPI 1548396054 · CMS profile ID 1232751

Allopathic & Osteopathic Physicians / Obstetrics & Gynecology / Gynecologic Oncology

SIOUX FALLS, SD

A name match is not confirmation of identity. CMS publishes records for different people under similar names; the NPI, specialty, and location shown on this page are the CMS-published fields that distinguish them.

A payment attributed to a provider may have been made to a third party — a hospital, practice, or research institution — rather than paid to the provider personally.

General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types

Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00

Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export.

Filtered page: https://industrypayments.org/provider/npi-1548396054?year=2023&recipient=provider#records-h

CMS source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9

Cite these filtered records

The citation includes this program year, filters, data edition, and page of results.

Plain
LUIS A ROJAS-ESPAILLAT, NPI 1548396054, CMS profile ID 1232751. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. IndustryPayments. https://industrypayments.org/provider/npi-1548396054?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
APA 7
IndustryPayments. (2026). LUIS A ROJAS-ESPAILLAT, NPI 1548396054, CMS profile ID 1232751. General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types. Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00. Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. [Filtered data set page]. https://industrypayments.org/provider/npi-1548396054?year=2023&recipient=provider#records-h. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9.
Bluebook
LUIS A ROJAS-ESPAILLAT, NPI 1548396054, CMS profile ID 1232751, IndustryPayments, General Payments, PY2023; Recipient scope: Physicians and non-physician practitioners; Reporting company: All reporting companies; Nature of payment: All payment types (Data edition: cms-20260630-workflow-20261105-v2; CMS publication: 2026-06-30; records imported: 2026-11-05T09:06:52.159882+00:00). Page 1 of 1; records 1–2 of 2 matching records. This page contains 2 records (maximum 50), not the full filtered export. Source: https://openpaymentsdata.cms.gov/dataset/fb3a65aa-c901-4a38-a813-b04b00dfa2a9. https://industrypayments.org/provider/npi-1548396054?year=2023&recipient=provider#records-h.

Centers for Medicare & Medicaid Services, Open Payments

Citation formats are provided for reference; check the requirements of your publication.

Payment records · PY2023

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

General Payments · PY2023 · Physicians and non-physician practitioners · CMS publication 2026-06-30

2 matching records · $2,616.35 reported total · 0 disputed

Nature of payment: All payment types

Records imported here (UTC).

Link to these filtered records · CMS source dataset ↗

Download all 2 matching records (CSV)

CSV includes CMS record IDs, source and publication dates, the data edition, and a link to these filters. Formula-like text cells are prefixed with an apostrophe for spreadsheet safety.

Showing records 1–2 of 2.

Paying entityAmountDate Nature of paymentDispute statusPublication flagsPublished Record IDSource
INTUITIVE SURGICAL, INC. $16.3507/25/2023 Food and Beverage No dispute reported Delay: No
Change: NEW
06/30/2026 1156528820 CMS
GlaxoSmithKline, LLC. $2,600.0005/24/2023 Consulting Fee No dispute reported Delay: No
Change: UNCHANGED
06/30/2026 1002699619 CMS

By program year

All program years on this page · sorted by year

Program yearAmountRecords
PY2019 $2,449.90 2
PY2021 $2,055.00 1
PY2022 $2,564.61 4
PY2023 $2,616.35 2
PY2025 $189.89 4

Source & provenance

Dataset
CMS Open Payments — General Payments
Publisher of source data
Centers for Medicare & Medicaid Services
CMS publication date
2026-06-30
Program years on this page
2019, 2021, 2022, 2023, 2025
Source files and profile matching
Source files
Dataset page · Bulk file · PY2019 , PY2021 , PY2022 , PY2023 , PY2025
Generated from
OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.

Research Payments

One row per program year and role, newest year first · amounts for the two roles are never added together

Program yearRoleAmountRecords
PY2025 Principal investigator $75,865.53 36
PY2024 Principal investigator $145,664.61 43
PY2023 Principal investigator $212,261.64 24
PY2022 Principal investigator $146,658.31 22
PY2021 Principal investigator $272,700.18 16
PY2020 Principal investigator $547,973.66 25
PY2019 Principal investigator $412,940.75 27

Research Payments are a separate CMS dataset, shown here separately and never added to General Payments. A research payment is often made to an institution, with this provider named as a principal investigator; each record states which role applies.

“If you are a physician who served as a principal investigator on a research study, you may see the payments associated with that research study listed under your name. This does not necessarily mean the payments are attributed to you. The dollar amount of the record corresponds to the total payment; the amounts are not attributed to each individual on the record.”

— Centers for Medicare & Medicaid Services, Open Payments Frequently Asked Questions, FAQ #12224

Research Payments records · PY2020

Ordering applied by this site (date, newest first, then paying entity) · record values are shown as CMS published them

25 records in PY2020

Research Payments records (CSV)

RolePaying entityAmount DateRecipientStudy Dispute statusPublishedRecord ID
Principal investigator 1 AstraZeneca Pharmaceuticals LP $805.80 12/31/2020 Covered Recipient Teaching Hospital
Avera Mckennan
A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with a germline BRCA mutation and Stage III-IV Ovarian Cancer who are in Complete or Partial Response Following First Line Platinum Based Chemotherapy No dispute reported 06/30/2026 736751425
Principal investigator 1 GlaxoSmithKline, LLC. $18,920.70 12/15/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734918605
Principal investigator 1 GlaxoSmithKline, LLC. $32,094.90 11/24/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734916079
Principal investigator 1 GlaxoSmithKline, LLC. $750.00 11/17/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734917805
Principal investigator 1 GlaxoSmithKline, LLC. $8,474.00 11/03/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734912665
Principal investigator 1 GlaxoSmithKline, LLC. $18,900.00 10/27/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734911751
Principal investigator 1 GlaxoSmithKline, LLC. $22,038.30 10/20/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734910733
Principal investigator 1 GlaxoSmithKline, LLC. $9,606.00 10/06/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734918411
Principal investigator 1 GlaxoSmithKline, LLC. $13,628.00 09/29/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734913087
Principal investigator 1 GlaxoSmithKline, LLC. $25,790.40 09/15/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734920101
Principal investigator 1 GlaxoSmithKline, LLC. $8,686.00 09/09/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734915747
Principal investigator 1 GlaxoSmithKline, LLC. $17,488.80 08/18/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734910731
Principal investigator 1 GlaxoSmithKline, LLC. $27,402.30 07/21/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734923445
Principal investigator 1 GlaxoSmithKline, LLC. $29,238.30 07/07/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734923443
Principal investigator 1 GlaxoSmithKline, LLC. $14,184.90 05/27/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734906745
Principal investigator 1 GlaxoSmithKline, LLC. $8,858.00 05/19/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734915745
Principal investigator 1 GlaxoSmithKline, LLC. $750.00 05/12/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734913083
Principal investigator 1 GlaxoSmithKline, LLC. $36,188.10 04/28/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734913135
Principal investigator 1 GlaxoSmithKline, LLC. $31,396.50 04/07/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734912031
Principal investigator 1 GlaxoSmithKline, LLC. $2,401.00 04/07/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734913081
Principal investigator 1 GlaxoSmithKline, LLC. $770.00 03/17/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734907165
Principal investigator 1 GlaxoSmithKline, LLC. $2,800.00 03/10/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734922139
Principal investigator 1 AstraZeneca Pharmaceuticals LP $12,363.26 02/27/2020 Covered Recipient Teaching Hospital
Avera Mckennan
A Phase III, Randomised, Double Blind, Placebo Controlled, Multicentre Study of Olaparib Maintenance Monotherapy in Patients with a germline BRCA mutation and Stage III-IV Ovarian Cancer who are in Complete or Partial Response Following First Line Platinum Based Chemotherapy No dispute reported 06/30/2026 736751603
Principal investigator 1 GlaxoSmithKline, LLC. $125,170.20 02/19/2020 Non-covered Recipient Entity
AVERA MCKENNAN DBA
A RANDOMIZED, DOUBLE-BLIND, PHASE 3 COMPARISON OF PLATINUM-BASED THERA No dispute reported 06/30/2026 734910453
Principal investigator 1 PFIZER INC. $79,268.20 02/13/2020 Covered Recipient Teaching Hospital
AVERA MCKENNAN
A RANDOMIZED OPENLABEL MULTICENTER PHASE 3 STUDY TO EVALUATE THE EFFICACY AND SAFETY OF AVELUMAB MSB0010718C IN COMBINATION WITH ANDOR FOLLOWING CHEMOTHERAPY IN PATIENTS WITH PREVIOUSLY UNTREATED EPITHELIAL OVARIAN CANCER JAVELIN OVARIAN 100 No dispute reported 06/30/2026 742908063